Incidence of diabetes following ramipril or rosiglitazone withdrawal.
OBJECTIVE: To examine the impact of withdrawing rosiglitazone and ramipril medication on diabetes incidence after closeout of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. RESEARCH DESIGN AND METHODS: The 3,366 DREAM subjects at trial end who had not de...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|